<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01255449</url>
  </required_header>
  <id_info>
    <org_study_id>FOT-BOS-01</org_study_id>
    <nct_id>NCT01255449</nct_id>
  </id_info>
  <brief_title>Respiratory Impedance and Obliterative Bronchiolitis</brief_title>
  <acronym>FOT-BOS</acronym>
  <official_title>Predictive Value of Within-breath Respiratory Input Impedance in the Early Diagnosis of Obliterative Bronchiolitis After Allogeneic Hematopoietic Stem Cell Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study will be to test the hypothesis that changes in within-breath
      total respiratory input impedance (Zrs) may provide an early evidence of obliterative
      bronchiolitis after allogeneic hematopoietic stem cell transplantation (HSCT). Before and
      after HSCT, Zrs will be measured by a modified forced oscillation technique (FOT) during
      spontaneous breathing both at baseline and 30 min after albuterol inhalation . Such technique
      may be particularly sensitive to small changes in lung mechanics observed in the early stages
      of peripheral airflow obstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1.0 INTRODUCTION

        -  Shortly after the introduction of allogeneic HSCT in clinical practice, it was
           recognized that standard pulmonary function tests (PFTs) are sensitive enough to detect
           HSCT-related respiratory complications [PMID: 2661259; PIMD: 8823260]. Accordingly, the
           finding of a progressive obstructive abnormality of new onset was considered as the
           functional hallmark of obliterative bronchiolitis (OB) [PMID: 16338616; PMID: 19896545].
           As a result, routinely performed spirometry has been proposed as a non-invasive tool to
           monitor the risk of OB in HSCT population [PMID: 17470622]. Yet, due to a peripheral
           airway involvement in OB, the sensitivity of conventional PFTs for early detection of OB
           is low [PMID: 2298060]. For instance, it does not exceed 75% in lung-transplanted
           population as the decrease of forced expiratory volume in 1 s (FEV1) may occur at a
           stage when the process is already irreversible and potentially life-threatening [PMID:
           9246138].

      2.0 EXPERIMENTAL HYPOTHESIS

        -  Because the branching pattern of the bronchial tree results in an increasingly large
           number of small airways with a luminal diameter of less than 2 mm in peripheral
           generations, these airways contribute little to total pulmonary resistance [PMID:
           5442364; PMID: 651978]. Intuitively, a large proportion of small airways may be damaged
           or obliterated without impairing any of the conventional PFTs. In this regard, a
           previous study [PMID: 12186817] pointed out that indexes of ventilation distribution may
           provide an early evidence of OB after lung transplantation. In particular, some authors
           [PMID: 12186817] have found that tests of ventilation distribution invariably
           deteriorated about 1 yr before a 20% decrease in FEV1 was apparent. Previous studies
           [PMID: 970731; PMID: 507525] showed that total respiratory input impedance (Zrs),
           measured by a forced oscillation technique (FOT) during spontaneous breathing, may be
           particularly sensitive to small changes in lung mechanics observed in the early stages
           of smoking-related airflow obstruction. Subsequently, it was developed a modified FOT to
           identify within-breath differences in Zrs, with values of Zrs representing the sum of
           respiratory system resistance (Rrs) and reactance (Xrs), the latter being the imaginary
           part of the former [PMID: 14979497; PMID: 19164347]. This method allows the assessment
           of more breaths and adds a potential quantitative evaluation of instantaneous
           inspiratory and expiratory Rrs and Xrs before and after external interventions such as a
           deep inspiration, bronchodilator drugs, etc. Although these effects can be identified
           when within-breath analysis is performed [PMID: 14979497], most published reports of
           oscillatory mechanics on chronic obstructive pulmonary disease (COPD) only report total
           respiratory cycle data [PMID: 1519830; PMID: 10489847].

      3.0 STUDY RATIONALE

        -  The aim of the present study will be to test the hypotheses that:

             1. post-HSCT changes in within-breath Rrs and Xrs may provide an earlier evidence of
                OB than standard PFTs. Indeed, the obliteration of terminal bronchioles, observed
                in up to 48% of OB patients following HSCT [PMID: 17470622], could make the real
                part of Zrs abnormally high [PMID: 5653219] and ventilation more heterogeneous;

             2. post-HSCT changes of airway responsiveness to acute bronchoactive interventions
                such as a deep inspiration to total lung capacity and/or a bronchodilator drug
                (i.e., albuterol) may be detected by our modified FOT. We speculate that these
                changes may represent an early sign of OB. Although a previous study from our group
                failed to find an increase in airway responsiveness after HSCT without pulmonary
                complications [PMID: 18684842], we have recently shown that airway smooth muscle
                tone may play an active role in the airflow obstruction of OB [PMID: 20724742].

      4.0 STUDY DESIGN

        -  Before and at regular intervals (2-4 wk onward) after HSCT, patients will attend our
           laboratory and perform all PFTs measurements in the same order. Firstly, the patient
           will breathe spontaneously through the modified FOT system for 5 min and then, without
           disconnecting from the apparatus, perform an inspiratory capacity maneuver and soon
           after resume spontaneous breathing for the next 2 min. Subsequently, spirometry,
           transmural total body plethysmography and CO diffusing capacity of the lung (standard
           PFTs) will be taken in triplicate. Thirty minutes after inhaling four separate doses of
           100 Î¼g of albuterol, the modified FOT measurements and standard PFTs will be repeated
           anew.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Airway Distensibility With Lung Inflation After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)</measure>
    <time_frame>2 weeks before and 2 months after HSCT</time_frame>
    <description>We studied 26 subjects, 2 weeks before and 2 months after HSCT. Within-breath respiratory system conductance (Grs) at 5, 11 and 19 Hz was measured by forced oscillation technique (FOT) at functional residual capacity (FRC) and total lung capacity (TLC)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-HSCT Changes in Lung Tissue Density</measure>
    <time_frame>Before and 2 months after HSCT</time_frame>
    <description>Changes in lung tissue density were measured by quantitative computed tomography(CT) scan 2 weeks before and 2 months after HSCT</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Hematopoietic Stem Cell Transplantation</condition>
  <condition>Obliterative Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>albuterol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twenty-six consecutive patients undergoing allogeneic HSCT for hematological malignancies were studied. All patients were in stable clinical conditions at the time of study. All patients received a myeloablative conditioning regimen either including or not including total body irradiation. Spirometry, lung volumes, FOT and lung CT scan were obtained before the start of conditioning treatment and, approximately, two months after HSCT. On each study day, all the above measurements were taken before and 30 min after inhaling four consecutive albuterol doses, of 100 mcg each, through a valved-holding chamber. DLco was measured only after bronchodilator inhalation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>albuterol</intervention_name>
    <description>400 mcg by inhalation</description>
    <arm_group_label>albuterol</arm_group_label>
    <other_name>Broncovaleas pressurized solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consecutive, clinically-stable, outpatients undergoing allogeneic HSCT (sourcing from
             bone marrow) for hematological malignancies

          -  values of standard PFTs within normal range before HSCT

          -  good collaboration during the maneuvers

        Exclusion Criteria:

          -  patients showing any spirometric and/or volumetric abnormality before HSCT

          -  poor collaboration and/or coordination during the maneuvers

          -  any clinically-significant respiratory disease (bronchial asthma, COPD, cystic
             fibrosis, etc.) before HSCT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Barisione, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>U.O. Medicina Preventiva e del Lavoro, Laboratorio di Fisiopatologia Respiratoria, IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>RodrÃ­guez-Roisin R, Roca J, GraÃ±ena A, AgustÃ­ AG, MarÃ­n P, Rozman C. Lung function in allogeneic bone marrow transplantation recipients. Eur Respir J. 1989 Apr;2(4):359-65.</citation>
    <PMID>2661259</PMID>
  </reference>
  <reference>
    <citation>Gore EM, Lawton CA, Ash RC, Lipchik RJ. Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):67-75.</citation>
    <PMID>8823260</PMID>
  </reference>
  <reference>
    <citation>Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56.</citation>
    <PMID>16338616</PMID>
  </reference>
  <reference>
    <citation>Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S106-14. doi: 10.1016/j.bbmt.2009.11.002. Epub 2009 Nov 5. Review.</citation>
    <PMID>19896545</PMID>
  </reference>
  <reference>
    <citation>Soubani AO, Uberti JP. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J. 2007 May;29(5):1007-19. Review.</citation>
    <PMID>17470622</PMID>
  </reference>
  <reference>
    <citation>Otulana BA, Higenbottam T, Ferrari L, Scott J, Igboaka G, Wallwork J. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest. 1990 Feb;97(2):353-7.</citation>
    <PMID>2298060</PMID>
  </reference>
  <reference>
    <citation>Van Muylem A, MÃ©lot C, Antoine M, Knoop C, Estenne M. Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation. Thorax. 1997 Jul;52(7):643-7.</citation>
    <PMID>9246138</PMID>
  </reference>
  <reference>
    <citation>Mead J. The lung's &quot;quiet zone&quot;. N Engl J Med. 1970 Jun 4;282(23):1318-9.</citation>
    <PMID>5442364</PMID>
  </reference>
  <reference>
    <citation>Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978 Jun 8;298(23):1277-81.</citation>
    <PMID>651978</PMID>
  </reference>
  <reference>
    <citation>Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med. 2002 Aug 15;166(4):440-4. Review.</citation>
    <PMID>12186817</PMID>
  </reference>
  <reference>
    <citation>Kjeldgaard JM, Hyde RW, Speers DM, Reichert WW. Frequency dependence of total respiratory resistance in early airway disease. Am Rev Respir Dis. 1976 Sep;114(3):501-8.</citation>
    <PMID>970731</PMID>
  </reference>
  <reference>
    <citation>Hayes DA, Pimmel RL, Fullton JM, Bromberg PA. Detection of respiratory mechanical dysfunction by forced random noise impedance parameters. Am Rev Respir Dis. 1979 Nov;120(5):1095-100.</citation>
    <PMID>507525</PMID>
  </reference>
  <reference>
    <citation>DellacÃ  RL, Santus P, Aliverti A, Stevenson N, Centanni S, Macklem PT, Pedotti A, Calverley PM. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J. 2004 Feb;23(2):232-40.</citation>
    <PMID>14979497</PMID>
  </reference>
  <reference>
    <citation>DellacÃ  RL, Pompilio PP, Walker PP, Duffy N, Pedotti A, Calverley PM. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD. Eur Respir J. 2009 Jun;33(6):1329-37. doi: 10.1183/09031936.00139608. Epub 2009 Jan 22.</citation>
    <PMID>19164347</PMID>
  </reference>
  <reference>
    <citation>Chalker RB, Celli BR, Habib RH, Jackson AC. Respiratory input impedance from 4 to 256 Hz in normals and chronic airflow obstruction: comparisons and correlations with spirometry. Am Rev Respir Dis. 1992 Sep;146(3):570-6.</citation>
    <PMID>1519830</PMID>
  </reference>
  <reference>
    <citation>FarrÃ© R, Peslin R, Rotger M, BarberÃ¡ JA, Navajas D. Forced oscillation total respiratory resistance and spontaneous breathing lung resistance in COPD patients. Eur Respir J. 1999 Jul;14(1):172-8.</citation>
    <PMID>10489847</PMID>
  </reference>
  <reference>
    <citation>Grimby G, Takishima T, Graham W, Macklem P, Mead J. Frequency dependence of flow resistance in patients with obstructive lung disease. J Clin Invest. 1968 Jun;47(6):1455-65.</citation>
    <PMID>5653219</PMID>
  </reference>
  <reference>
    <citation>Barisione G, Bacigalupo A, Crimi E, Van Lint MT, Lamparelli T, Brusasco V. Changes in lung volumes and airway responsiveness following haematopoietic stem cell transplantation. Eur Respir J. 2008 Dec;32(6):1576-82. doi: 10.1183/09031936.0139807. Epub 2008 Aug 6.</citation>
    <PMID>18684842</PMID>
  </reference>
  <reference>
    <citation>Barisione G, Bacigalupo A, Crimi E, Brusasco V. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation. Chest. 2011 Mar;139(3):633-639. doi: 10.1378/chest.10-1442. Epub 2010 Aug 19.</citation>
    <PMID>20724742</PMID>
  </reference>
  <results_reference>
    <citation>Barisione G, Pompilio PP, Bacigalupo A, Brusasco C, CioÃ¨ A, DellacÃ  RL, Lamparelli T, Garlaschi A, Pellegrino R, Brusasco V. Airway distensibility with lung inflation after allogeneic haematopoietic stem-cell transplantation. Respir Physiol Neurobiol. 2012 Oct 15;184(1):80-5. doi: 10.1016/j.resp.2012.07.021. Epub 2012 Aug 8.</citation>
    <PMID>22898044</PMID>
  </results_reference>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2010</study_first_submitted>
  <study_first_submitted_qc>December 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2010</study_first_posted>
  <results_first_submitted>September 18, 2012</results_first_submitted>
  <results_first_submitted_qc>December 22, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 31, 2013</results_first_posted>
  <last_update_submitted>December 22, 2012</last_update_submitted>
  <last_update_submitted_qc>December 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</investigator_affiliation>
    <investigator_full_name>Giovanni Barisione</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Forced oscillation technique</keyword>
  <keyword>Respiratory input impedance</keyword>
  <keyword>Allogeneic hematopoietic stem cell transplantation</keyword>
  <keyword>Obliterative bronchiolitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis Obliterans</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuterol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The recruitment started on 10-Nov-2010 and finished on 15-feb-2012. The recruitment was performed at Pulmonary Function Tests Laboratory of IRCCS AOU San Martino.</recruitment_details>
      <pre_assignment_details>All patients were in stable clinical conditions and none had a history of significant respiratory disease.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Albuterol</title>
          <description>On each study day, all lung function measurements were taken before and 30 min after inhaling four consecutive albuterol doses of 100 mcg each, through a valved-holding chamber. Lung diffusing capacity for carbon monoxide was measured only after bronchodilator inhalation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Albuterol</title>
          <description>All recruited subjects underwent an acute bronchodilation with albuterol following baseline pulmonary function measurements.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Airway Distensibility With Lung Inflation After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)</title>
        <description>We studied 26 subjects, 2 weeks before and 2 months after HSCT. Within-breath respiratory system conductance (Grs) at 5, 11 and 19 Hz was measured by forced oscillation technique (FOT) at functional residual capacity (FRC) and total lung capacity (TLC)</description>
        <time_frame>2 weeks before and 2 months after HSCT</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Airway Distensibility With Lung Inflation After HSCT</title>
            <description>Changes in airway conductance at 5 Hz (Grs5) were related to changes in lung volume (DeltaGrs5/DeltaVL) to estimate airway distensibility</description>
          </group>
        </group_list>
        <measure>
          <title>Airway Distensibility With Lung Inflation After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)</title>
          <description>We studied 26 subjects, 2 weeks before and 2 months after HSCT. Within-breath respiratory system conductance (Grs) at 5, 11 and 19 Hz was measured by forced oscillation technique (FOT) at functional residual capacity (FRC) and total lung capacity (TLC)</description>
          <units>1/cmH2O*s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-HSCT Changes in Lung Tissue Density</title>
        <description>Changes in lung tissue density were measured by quantitative computed tomography(CT) scan 2 weeks before and 2 months after HSCT</description>
        <time_frame>Before and 2 months after HSCT</time_frame>
        <population>CT scans, in a format suitable for software analysis, were available in 8 patients only</population>
        <group_list>
          <group group_id="O1">
            <title>Post-HSCT Changes in Lung Tissue Density</title>
            <description>In eight out of 26 patients, a quantitative CT scan analysis was conducted to measure changes in lung tissue density</description>
          </group>
        </group_list>
        <measure>
          <title>Post-HSCT Changes in Lung Tissue Density</title>
          <description>Changes in lung tissue density were measured by quantitative computed tomography(CT) scan 2 weeks before and 2 months after HSCT</description>
          <population>CT scans, in a format suitable for software analysis, were available in 8 patients only</population>
          <units>g/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Albuterol</title>
          <description>All subjects underwent an acute bronchodilation with albuterol by inhaling four consecutive doses (100 mcg each)of the drug through a valved-holding chamber</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Giovanni Barisione</name_or_title>
      <organization>IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy</organization>
      <phone>+39010555 ext 3367</phone>
      <email>giovanni.barisione@hsanmartino.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

